Clinical conundrums involving statin drug-drug interactions
- 15 November 2022
- journal article
- review article
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 75, 83-89
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The P-Glycoprotein Transport System and Cardiovascular DrugsJACC, 2013
- Statins and daptomycin: safety assessment of concurrent use and evaluation of drug interaction liabilityDrug Metabolism and Drug Interactions, 2013
- Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation CandidatesJACC, 2012
- The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipientsThe Journal of Heart and Lung Transplantation, 2010
- Conversion to Tacrolimus and Atorvastatin in Cyclosporine-treated Heart Transplant Recipients With Dyslipidemia Refractory to FluvastatinThe Journal of Heart and Lung Transplantation, 2009
- Coadministration of Dabigatran Etexilate and AtorvastatinAmerican Journal of Cardiovascular Drugs, 2009
- Clinical Pharmacokinetics and Pharmacodynamics of the Oral Direct Thrombin??Inhibitor Dabigatran EtexilateClinical Pharmacokinetics, 2008
- Role of P‐glycoprotein in Statin Drug InteractionsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2006
- Drug Therapy in the Heart Transplant RecipientCirculation, 2005
- FDA Adverse Event Reports on Statin-Associated RhabdomyolysisAnnals of Pharmacotherapy, 2002